← Leaderboards
James Barrow
Lieber Institute, Inc.
$5,379,220
Attributed
$6,688,572
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $915.6K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,688,572 · 3
By mechanism
R01$6,605,339 · 2
R03$83,233 · 1
Top collaborators
- Gregory V Carr3 shared
- Marc Ferrer2 shared
- Daniel Weinberger2 shared
Most similar at Lieber Institute, Inc.
Same institution · by research overlap
- Gregory V Carr$2,338,517
- Marc Ferrer$27,744
- Daniel Weinberger$4,679,907
- Keri Martinowich$17,653,479
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoBrainDopamineAdverse EffectsPlasmaPlayPenetrationScreeningValidationTherapeutic TargetPharmacodynamicsBehaviorMetabolicMediatingIn VitroPrefrontal CortexDesignClinical ResearchFamilyDrug KineticsImpaired CognitionLeadInhibitor/AntagonistAffect
Grant awards (10)
Small-molecule probes for augmenting D5 receptor signaling$832,301
R01 · FY2025 · MH
Small-molecule probes for augmenting D5 receptor signaling$837,713
R01 · FY2024 · MH
Small-molecule probes for augmenting D5 receptor signaling$837,713
R01 · FY2023 · MH
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia$779,257
R01 · FY2019 · MH · contact PI
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia$787,626
R01 · FY2018 · MH · contact PI
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia$805,808
R01 · FY2017 · MH · contact PI
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia$809,271
R01 · FY2016 · MH · contact PI
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia$915,650
R01 · FY2015 · MH · contact PI
High Throughput Screening for Specific Inhibitors and Modulators of A Novel Potas$40,983
R03 · FY2013 · MH · contact PI
High Throughput Screening for Specific Inhibitors and Modulators of A Novel Potas$42,250
R03 · FY2012 · MH · contact PI